Table 1.
Healthy controls (n = 18) | Multiple sclerosis (n = 18) | |
---|---|---|
Age (years), mean(SD) | 43.9 (10.8) | 41.3 (10.0) |
Female sex, n(%) | 13 (72.2) | 13 (72.2) |
Race | ||
Caucasian | 16 | 16 |
African American | 2 | 2 |
Disease duration (years), mean(SD) | – | 9.8 (6.2) |
EDSS, median (IQR) | – | 2 (1.5) |
Previous treatment | ||
None | – | 6 |
Glatiramer | – | 5 |
Interferon beta | – | 5 |
Natalizumab | – | 2 |
Lymphopenia | ||
None | – | 10 |
Grade 1 | – | 2 |
Grade 2 | – | 5 |
Grade 3 | – | 1 |